Special: Tiny Glitch Could Kill 5G Technology

SCORE

30

GH: Guardant Health Inc is a Sell


The current rating for GH is 30, which is 67% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.